Bevacizumab (Avastin) News, Updated Regularly

GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade ... - Earthtimes
November 19, 2008, 3:43 am

GAITHERSBURG, Md. - (Business Wire) GenVec, Inc. (Nasdaq:GNVC) announced today top-line results of an interim analysis from its ongoing Phase III Pancreatic Cancer Clinical Trial with TNFerade? (PACT) in patients with locally advanced pancreatic ...

Genentech disputes new Avastin research data - San Francisco Gate
November 19, 2008, 5:52 am

Wednesday, November 19, 2008 The risk of the worrisome blood clots was 33 percent higher among those on Avastin compared with control group subjects in 15 clinical trials analyzed together, Dr. Shenhong Wu and his colleagues reported late Tuesday in ...

5 Health Care Stocks for Value Investors - Seekingalpha.com
November 19, 2008, 3:07 am

In no way do I feel the market has bottomed out or that the credit crisis has skidded to a halt, but in the words of Warren Buffett, ?Be fearful when others are greedy and be greedy when others are fearful.? What does this mean for you, an ...

Popular cancer drug 'increases blood clot risk' - New Kerala
November 19, 2008, 5:09 am

Washington, Nov 19 : After analysing randomised controlled trials, scientists have found that cancer drug bevacizumab significantly increases the risk of venous thromboembolism, i.e. blood clots in the deep veins of the legs or in the lungs. It was ...

Cancer Drug Avastin Raises Blood Clot Risk - WebMD
November 18, 2008, 10:46 am

Nov. 18, 2008 -- The life-extending cancer drug Avastin raises the risk of dangerous blood clots by 33%, an analysis of clinical-trial data shows. Nearly 12% of patients taking Avastin get blood clots, with 6.3% developing clots serious enough to ...

Cancer Drug Ups Risk of Clots in Veins - Atlanta Journal Constitution
November 19, 2008, 12:22 am

TUESDAY, Nov. 18 (HealthDay News) -- The widely used cancer drug Avastin appears to be associated with a greater risk of developing blood clots in the veins of patients with a variety of cancers. This risk lengthens an already long list of severe ...

Cancer drug Avastin ups blood clotting risk - Food Consumer
November 19, 2008, 10:52 am

Wednesday Nov 19, 2008 (foodconsumer.org) -- Use of cancer drug Avastin as part of chemotherapy raises the risk of blood clots in the veins by 30 percent, according to a new study published in the Journal of the American Medical Association. The ...

New Hampshire?s Drug Privacy Law Upheld - Eflux Media
November 19, 2008, 5:52 am

A federal appeals court on Tuesday upheld New Hampshire ?s law that restricts drug companies access to some information about doctor?s prescription drug data that is widely used in pharmaceutical marketing. The law prohibits pharmacies, benefits ...

Combination of carboplatin and paclitaxel with bevacizumab and ... - News-Medical.Net
November 17, 2008, 2:41 am

The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by ...

Four drug combination helps in lung cancer: U.S. study - Reuters
November 13, 2008, 9:41 am

WASHINGTON (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S. researchers reported on Thursday. The combination of Roche and Co's Avastin ...

Are you looking for additional Avastin (Bevacizumab) news? Try our new "Bevacizumab News Focus" area.

Are you looking for additional Avastin (Bevacizumab) information? Try our new "Bevacizumab Related Blog Entries" area.

Off-site Bevacizumab (Avastin) Links, User Submitted

The following links have been collected through user bookmark submission in the Bevacizumab_Avastin category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Mon Nov 10

• Cancer Drugs May Build And Not Tear Down Blood Vessels
• ScienceDirect - The Lancet : Cost-effective ness considerations at NICE

Sun Oct 5

• Genetic tests may pinpoint who should get Avastin | Industries | Healthcare | Reuters

Tue Sep 9

• Avastin Macular Degeneration - Bevacizumab

Mon Sep 1

• Normalizing Tumor Vessels To Improve Cancer Therapy: Chemotherapy drugs often never reach the tumors they're intended to treat, and radiation therapy is not always effective, because the blood vessels feeding the tumors are abnormal?" ;leaky and twisty". Adding VEGF therapy such as Avastin to standard chemo normalises the capillaries and allows more chemo to enter the tumour, thereby shrinking it.

Tue Aug 26

• Bevacizumab Improves PFS in Advanced Breast Cancer - Cancer Network

Mon Aug 18

• Scientific Literature Alerts: Bevacizumab gbm irinotecan

Fri Jul 11

• Bevacizumab shows significant activity in liver cancer - ASCO

Mon May 12

• Bacillus cereus endophthalmiti s following intravitreous bevacizumab injection.: The first case of Bacillus cereus endophthalmiti s following an intravitreous injection of bevacizumab is described. A 77-year-old man presented to a retina specialist with an active choroidal neovasculariza tion.

Tue Apr 22

• Efficacy and safety of bevacizumab plus erlotinib ...[Gynecol Oncol. 2008] - PubMed Result: PubMed is a service of the U.S. National Library of Medicine that includes over 16 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s.

Tue Jan 1

• NEJM -- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
• NEJM -- Paclitaxel-Car boplatin Alone or with Bevacizumab for Non-Small-Cell Lung Cancer

Sat Dec 29

• Outcomes for Elderly, Advanced-Stage Non Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 -- Ramalingam et al. 26 (1): 60 -- Journal of Clini

Wed Dec 26

• NEJM -- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Sat Dec 22

• Medical News: SNO: Bevacizumab-Ir inotecan Combination Boosts Progression-Fr ee Survival in Relapsed Glioblastoma - in Neurology, Brain Cancer from MedPage Today

Off-site Bevacizumab Research Links

If you still need additional information on Bevacizumab then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.